UCOMB-real life data: treatment strategies for chronic urticaria patients with comorbidities
CONCLUSIONS: Combining treatment modalities for chronic urticaria and comorbidities are available and feasible with a good safety profile.PMID:38508226 | DOI:10.1080/09546634.2024.2329784 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - March 20, 2024 Category: Dermatology Authors: Petra Staubach Benedikt Bilo Joachim W Fluhr Karoline Krause Kanokvalai Kulthanan Andac Salman Connie Katelaris Jonathan A Bernstein Marcus Maurer Caroline Mann Source Type: research
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
CONCLUSIONS: The most frequently reported suspected ADRs of asthma biologics in VigiBase confirmed the presence of well-known adverse effects such as general disorders, injection-site reactions, nasopharyngitis, headache and hypersensitivity, while some others (e.g. asthma reactivation or therapeutic failure) could be ascribed to the indication of use. Moreover, the analysis of signals of disproportionate reporting suggests the presence of malignancies, effects on the cardiovascular system, alopecia and autoimmune conditions, requiring further assessment and investigation.PMID:38489062 | DOI:10.1007/s40259-024-00653-6 (Source: Herpes)
Source: Herpes - March 15, 2024 Category: Infectious Diseases Authors: Paola Maria Cutroneo Elena Arzenton Fabiana Furci Fabio Scapini Maria Bulzom ì Nicoletta Luxi Marco Caminati Gianenrico Senna Ugo Moretti Gianluca Trifir ò Source Type: research
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
CONCLUSIONS: The most frequently reported suspected ADRs of asthma biologics in VigiBase confirmed the presence of well-known adverse effects such as general disorders, injection-site reactions, nasopharyngitis, headache and hypersensitivity, while some others (e.g. asthma reactivation or therapeutic failure) could be ascribed to the indication of use. Moreover, the analysis of signals of disproportionate reporting suggests the presence of malignancies, effects on the cardiovascular system, alopecia and autoimmune conditions, requiring further assessment and investigation.PMID:38489062 | DOI:10.1007/s40259-024-00653-6 (Source: Herpes)
Source: Herpes - March 15, 2024 Category: Infectious Diseases Authors: Paola Maria Cutroneo Elena Arzenton Fabiana Furci Fabio Scapini Maria Bulzom ì Nicoletta Luxi Marco Caminati Gianenrico Senna Ugo Moretti Gianluca Trifir ò Source Type: research
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
ConclusionsThe most frequently reported suspected ADRs of asthma biologics in VigiBase confirmed the presence of well-known adverse effects such as general disorders, injection-site reactions, nasopharyngitis, headache and hypersensitivity, while some others (e.g. asthma reactivation or therapeutic failure) could be ascribed to the indication of use. Moreover, the analysis of signals of disproportionate reporting suggests the presence of malignancies, effects on the cardiovascular system, alopecia and autoimmune conditions, requiring further assessment and investigation. (Source: BioDrugs)
Source: BioDrugs - March 15, 2024 Category: Drugs & Pharmacology Source Type: research
